SCHEMBL453523

SCHEMBL453523

CC1(C)CC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17863707 0.76
SCHEMBL387979 0.76
SCHEMBL4633004 0.76 FFAR3 (0.37)
SCHEMBL15247338 0.76
SCHEMBL17679770 0.73
SCHEMBL5305883 0.72
SCHEMBL14175334 0.72
SCHEMBL7117026 0.72
SCHEMBL1502910 0.72
SCHEMBL10203095 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024245356-A1 M-AMIDOBENZOIC ACID BISAMIDE COMPOUND AND INTERMEDIATE THEREOF 湖南化工研究院有限公司 2024-12-05 WO claimed
EP-2829555-B1 METHOD FOR PRODUCING OLEFIN POLYMER MITSUI CHEMICALS INC (JP) 2018-05-16 EP claimed
US-9315602-B2 Method for producing olefin polymer MITSUI CHEMICALS, INC. (JP) 2016-04-19 US claimed
EP-2217239-A2 MODULATION OF PROTEIN TRAFFICKING Foldrx Pharmaceuticals, Inc. (US) 2010-08-18 EP claimed
WO-2009062118-A2 MODULATION OF PROTEIN TRAFFICKING FOLDRX PHARMACEUTICALS, INC. (US) 2009-05-14 WO claimed
EP-0206167-B1 TETRAMETHYLCYCLOPROPANECARBONIC ACID ESTERS BAYER AG (DE) 1989-01-04 EP claimed
US-12540073-B2 Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor BRILLIANT LIGHT POWER, INC. (US) 2026-02-03 US disclosed
US-20250057798-A1 THERAPEUTIC USE OF COMPOUNDS UCL BUSINESS LTD (GB) 2025-02-20 US disclosed
WO-2024245356-A1 M-AMIDOBENZOIC ACID BISAMIDE COMPOUND AND INTERMEDIATE THEREOF 湖南化工研究院有限公司 2024-12-05 WO disclosed
US-12090131-B2 Therapeutic use of compounds UCL BUSINESS LTD (GB) 2024-09-17 US disclosed
US-20230146709-A1 THERAPEUTIC USE OF COMPOUNDS UCL BUSINESS LTD (GB) 2023-05-11 US disclosed
US-20230045778-A9 HETEROGENEOUS HYDROGEN-CATALYST SOLID FUEL REACTION MIXTURE AND REACTOR BRILLIANT LIGHT POWER, INC. (US) 2023-02-09 US disclosed
US-11491127-B2 Therapeutic use of compounds UCL BUSINESS PLC (GB) 2022-11-08 US disclosed
WO-1995021814-A1 NOVEL DERIVATIVES OF TETRAMETHYLCYCLOPROPANE TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 1995-08-17 WO disclosed
US-5126461-A Silica in organic solution SHELL RESEARCH LIMITED (GB) 1992-06-30 US disclosed
US-5120861-A DIAZIRINE DERIVATIVES OF AROMATIC HETEROCYCLIC COMPOUNDS SHELL RESEARCH LIMITED (GB) 1992-06-09 US disclosed
EP-0432818-A2 Process for opening cyclopropane rings SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1991-06-19 EP disclosed
EP-0432817-A1 Diazirine derivatives of aromatic heterocyclic compounds SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1991-06-19 EP disclosed
EP-0018894-B1 ESTERS OF ALLETHROLONE DERIVATIVES AND CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1982-02-17 EP disclosed
EP-0018894-A1 Esters of allethrolone derivatives and carboxylic acids, process for their preparation and the compositions containing them ROUSSEL-UCLAF (FR) 1980-11-12 EP disclosed